ReviewJournal of inflammation research2024

The Potential of Neuregulin 4 as a Novel Biomarker and Therapeutic Agent for Vascular Complications in Type 2 Diabetes Mellitus.

Xiaofang Dan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.